Blueprint Medicines Corp (LTS:0HOJ) Stock News, Headlines & Updates
Blueprint Medicines Corp Stock News from GuruFocus
- 1
Jun 18, 2024
Investors Have the Opportunity to Join the Following Securities Fraud Investigations: Avangrid, Inc. (AGR), Squarespace, Inc. (SQSP), and Blueprint Medicines Corporation (BPMC)
PRNewswire • 8:00pm
Jun 13, 2024
Investors Have the Opportunity to Join the Following Securities Fraud Investigations: Avangrid, Inc. (AGR), Squarespace, Inc. (SQSP), and Blueprint Medicines Corporation (BPMC)
PRNewswire • 5:00pm
Jun 08, 2024
Insider Sale: Chief Scientific Officer Percy Carter Sells Shares of Blueprint Medicines Corp (BPMC)
GuruFocus Research • 7:15pm
Jun 06, 2024
Insider Sale at Blueprint Medicines Corp (BPMC): Chief Medical Officer L. Hewes Sells Shares
GuruFocus Research • 5:01pm
May 30, 2024
Blueprint Medicines Announces Data Presentations at EAACI and EHA Annual Meetings Highlighting Sustained Clinical Benefits of AYVAKIT®/AYVAKYT® (avapritinib)
PRNewswire • 6:00pm
May 27, 2024
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Blueprint Medicines Corporation and Encourages Investors to Contact the Firm
Marketwired • 8:00pm
May 23, 2024
BPMC INVESTOR ALERT: Andrews & Springer LLC Investigates Blueprint Medicines Corporation
Marketwired • 10:00am
May 20, 2024
BPMC Alert: The Law Firm of Andrews & Springer LLC Is Investigating Blueprint Medicines Corporation For Potential Securities Violations and Breaches of Fiduciary Duty
Marketwired • 8:00am
May 06, 2024
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRNewswire • 4:00pm
May 03, 2024
Blueprint Medicines Corp (BPMC) (Q1 2024) Earnings Call Transcript Highlights: Surpassing Expectations and Strategic Advances
GuruFocus Research • 1:05am
Q1 2024 Blueprint Medicines Corp Earnings Call Transcript
GuruFocus Research • 11:13pm
May 02, 2024
Blueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
PRNewswire • 7:00am
Blueprint Medicines Corp Reports Q1 2024 Earnings, Surpasses Revenue Estimates and Raises Full-Year Guidance
GuruFocus Research • 6:36am
Apr 18, 2024
Blueprint Medicines to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
PRNewswire • 8:00am
Apr 11, 2024
Blueprint Medicines to Host Webcast and Conference Call Highlighting Emerging Opportunities for Mast Cell-Targeted Therapeutics
PRNewswire • 8:00am
Apr 04, 2024
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRNewswire • 4:00pm
Mar 23, 2024
Blueprint Medicines Corp Director Jeffrey Albers Sells 25,073 Shares
GuruFocus Research • 11:25pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news